Skip to Main Content
HBS Home
  • About
  • Academic Programs
  • Alumni
  • Faculty & Research
  • Baker Library
  • Giving
  • Harvard Business Review
  • Initiatives
  • News
  • Recruit
  • Map / Directions
Faculty & Research
  • Faculty
  • Research
  • Featured Topics
  • Academic Units
  • …→
  • Harvard Business School→
  • Faculty & Research→
  • Research
    • Research
    • Publications
    • Global Research Centers
    • Case Development
    • Initiatives & Projects
    • Research Services
    • Seminars & Conferences
    →
  • Publications→

Publications

Publications

Filter Results: (3,240) Arrow Down
Filter Results: (3,240) Arrow Down Arrow Up

Show Results For

  • All HBS Web  (3,240)
    • People  (5)
    • News  (433)
    • Research  (2,454)
    • Events  (16)
    • Multimedia  (15)
  • Faculty Publications  (1,672)

Show Results For

  • All HBS Web  (3,240)
    • People  (5)
    • News  (433)
    • Research  (2,454)
    • Events  (16)
    • Multimedia  (15)
  • Faculty Publications  (1,672)
← Page 52 of 3,240 Results →
  • August 2020
  • Article

A History of Prescription Drug Monitoring Programs in the United States: Political Appeal and Public Health Efficacy

By: A Jay Holmgren, Alyssa Botelho and Allan M Brandt
Prescription drug monitoring programs (PDMPs) have become a widely embraced policy to address the US opioid crisis. Despite mixed scientific evidence on their effectiveness at improving health and reducing overdose deaths, 49 states and Washington, DC have adopted... View Details
Keywords: Health Disorders; Information Technology; Programs; Technology Adoption; History; Government and Politics; Policy; United States
Citation
Register to Read
Related
Holmgren, A Jay, Alyssa Botelho, and Allan M Brandt. "A History of Prescription Drug Monitoring Programs in the United States: Political Appeal and Public Health Efficacy." American Journal of Public Health 110, no. 8 (August 2020).
  • 22 Jul 2013
  • News

Massive Deleveraging Suffocating Job Growth

  • September 2019
  • Case

Clean Energy for the Future

By: Richard H.K. Vietor and Howaida Kamel
This is an industry note on renewable energy – wind, solar, governmental incentives and storage. It covers the recent history of both the wind and solar industries, an extensive look at governmental policies in the United States, including the Green New Deal, and... View Details
Keywords: Green New Deal; Renewable Energy; Energy Policy; Industry Growth; Supply and Industry; Price; Motivation and Incentives; Energy Industry; Green Technology Industry; United States
Citation
Educators
Purchase
Related
Vietor, Richard H.K., and Howaida Kamel. "Clean Energy for the Future." Harvard Business School Case 720-003, September 2019.
  • 11 Oct 2021
  • News

Nobel Winners Found Economic Experiments in the Real World

  • Article

Why Compliance Programs Fail: And How to Fix Them

By: Hui Chen and Eugene Soltes
Firms spend millions of dollars annually on whistle-blower hotlines, training, and other efforts to ensure adherence to laws, regulations, and company policies. Yet malfeasance remains entrenched in the corporate world. Why? Too many firms treat compliance as a... View Details
Keywords: Governance Compliance; Programs; Employees; Training; Performance Effectiveness; Measurement and Metrics
Citation
Find at Harvard
Register to Read
Related
Chen, Hui, and Eugene Soltes. "Why Compliance Programs Fail: And How to Fix Them." Harvard Business Review 96, no. 2 (March–April 2018): 116–125.

    Economic Analysis of the Digital Economy

    As the cost of storing, sharing, and analyzing data has decreased, economic activity has become increasingly digital. But while the effects of digital technology and improved digital communication have been explored in a variety of contexts, the impact on... View Details
    • September 2019
    • Article

    The Effect of Enforcement Transparency: Evidence from SEC Comment-Letter Reviews

    By: Miguel Duro, Jonas Heese and Gaizka Ormazabal
    This paper studies the effect of the public disclosure of the Securities and Exchange Commission (SEC) comment-letter reviews (CLs) on firms’ financial reporting. We exploit a major change in the SEC’s disclosure policy: in 2004, the SEC decided to make its CLs... View Details
    Keywords: Disclosure; SEC Comment-Letter Reviews; Public Enforcement; Governance; Information Publishing; Policy; Financial Reporting; Capital Markets; Organizational Change and Adaptation
    Citation
    SSRN
    Find at Harvard
    Related
    Duro, Miguel, Jonas Heese, and Gaizka Ormazabal. "The Effect of Enforcement Transparency: Evidence from SEC Comment-Letter Reviews." Review of Accounting Studies 24, no. 3 (September 2019): 780–823.
    • January 2022 (Revised November 2023)
    • Supplement

    Uber in China (C): The Cost of Success for Didi

    By: William C. Kirby and Noah B. Truwit
    On June 30, 2021, ride-hailing giant Didi Chuxing (Didi) raised $4.4 billion in its initial public offering (IPO) on the New York Stock Exchange (NYSE), the largest IPO of a Chinese company listed on an American exchange since Alibaba raised $25 billion in 2014.... View Details
    Keywords: Uber; Didi Chuxing; Start-up Growth; Regulation; Ride-sharing; Transportation; Business Startups; Business and Government Relations; Cross-Cultural and Cross-Border Issues; Growth and Development; Policy; Competition; Laws and Statutes; Transportation Industry; Technology Industry; China
    Citation
    Purchase
    Related
    Kirby, William C., and Noah B. Truwit. "Uber in China (C): The Cost of Success for Didi." Harvard Business School Supplement 322-068, January 2022. (Revised November 2023.)
    • February 2023
    • Article

    A Different Framework to Achieve Universal Coverage in the U.S.

    By: Katherine Baicker, Amitabh Chandra and Mark Shepard
    This JAMA Forum discusses alternative ways to achieve universal coverage in the US such as administrative simplification in the Affordable Care Act plans to increase enrollment, having a basic policy that would be available to everyone, and options for supplemental... View Details
    Keywords: Health Care and Treatment; Government Legislation; Insurance; Cost; United States
    Citation
    Register to Read
    Related
    Baicker, Katherine, Amitabh Chandra, and Mark Shepard. "A Different Framework to Achieve Universal Coverage in the U.S." e230187. JAMA Health Forum 4, no. 2 (February 2023).
    • 2023
    • Working Paper

    The Politics of Philanthropy in China

    By: Geoffrey Jones and Yuhai Wu
    This working paper looks historically at business philanthropy in China. In the West, the literature has distinguished between entrepreneurial and customary philanthropy, while the phenomenon of spiritual philanthropy has been identified in many emerging markets. This... View Details
    Keywords: China; Philanthropy; Ethics; Philanthropy and Charitable Giving; Moral Sensibility; Corporate Social Responsibility and Impact; Economic Systems; Economic Sectors; China
    Citation
    Read Now
    Related
    Jones, Geoffrey, and Yuhai Wu. "The Politics of Philanthropy in China." Harvard Business School Working Paper, No. 23-067, May 2023.
    • 2019
    • Working Paper

    Fiscal Rules and Sovereign Default

    By: Laura Alfaro and Fabio Kanczuk
    Recurrent concerns over debt sustainability in emerging and developed nations have prompted renewed debate on the role of fiscal rules. Their optimality, however, remains unclear. We provide a quantitative analysis of fiscal rules in a standard model of sovereign debt... View Details
    Keywords: Sovereign Debt; Hyperbolic Discounting; Fiscal Rules; Sovereign Finance
    Citation
    Read Now
    Related
    Alfaro, Laura, and Fabio Kanczuk. "Fiscal Rules and Sovereign Default." Harvard Business School Working Paper, No. 16-134, June 2016. (Also NBER Working Paper w23370. Revised January 2019.)
    • 01 Nov 2021
    • News

    The US Has New COVID Vaccine Rules for International Travelers. Here’s What to Know

    • Web

    Faculty & Research

    bias with naive beliefs. The government chooses mandatory contributions to accounts, each with a different pre-retirement withdrawal penalty. Collected penalties are rebated lump sum. When households have homogeneous present bias, , the... View Details
    • 02 Feb 2021
    • Blog Post

    Finding My Focus in Health care Amidst a Global Pandemic

    decade, legislators have passed countless health care policies that impact how hospitals, insurance companies and pharmaceutical manufacturers deliver services to patients. Even more, the ongoing SARS-CoV-2 pandemic has uncovered major... View Details
    • 16 Mar 2010
    • First Look

    First Look: March 16

    had full access to corporate archives and executives and provides us with a unique insight into the workings and strategies of one of the world's oldest and largest multinationals. Capitalism: Its Origins and Evolution As a System of View Details
    Keywords: Martha Lagace
    • February 2007 (Revised November 2007)
    • Case

    Latvia: Economic Strategy after EU Accession

    By: Michael E. Porter and Christian H.M. Ketels
    Describes the economic development of Latvia, a small eastern European country on the shores of the Baltic Sea, from regaining independence in 1991 to European Union (EU) accession in 2004 and is set on May 1st, 2004, the day Latvia became an EU member. Latvia had... View Details
    Keywords: Developing Countries and Economies; Economic Growth; Policy; Business and Government Relations; European Union; Latvia
    Citation
    Educators
    Purchase
    Related
    Porter, Michael E., and Christian H.M. Ketels. "Latvia: Economic Strategy after EU Accession." Harvard Business School Case 707-515, February 2007. (Revised November 2007.)
    • April 2017
    • Supplement

    Imprimis (B)

    By: Ramon Casadesus-Masanell, Karen Elterman and Marc Appel
    This case is a supplement to Imprimis (A). It describes the company’s decision to enter into the pharmaceutical compounding business in 2013–2014. Imprimis purchased a compounded ophthalmological medication called Dropless Therapy, which was injected into patients’... View Details
    Keywords: Healthcare; Drug Compounding; Drug Development; Pharmaceuticals; Small Business; Decision-making, Business Model; Mark Baum; Imprimis; Decision Making; Strategy; Health Care and Treatment; Policy; Pharmaceutical Industry; United States
    Citation
    Purchase
    Related
    Casadesus-Masanell, Ramon, Karen Elterman, and Marc Appel. "Imprimis (B)." Harvard Business School Supplement 717-496, April 2017.
    • 11 Feb 2008
    • Research & Ideas

    Does Democracy Need a Marketing Manager?

    citizen needs, developing policy and program solutions, informing interested citizens about themselves, and making themselves easily accessible. They should embrace reforms, such as lifelong voter registration, that remove barriers to... View Details
    Keywords: by Sean Silverthorne
    • 04 Jun 2008
    • Working Paper Summaries

    Accountability and Inequality in Single-Party Regimes: A Comparative Analysis of Vietnam and China

    Keywords: by Regina Abrami, Edmund Malesky & Yu Zheng
    • 03 Oct 2017
    • News

    Mass Shootings Don't Lead to Inaction—They Lead to Loosening Gun Restrictions

    • ←
    • 52
    • 53
    • …
    • 161
    • 162
    • →
    ǁ
    Campus Map
    Harvard Business School
    Soldiers Field
    Boston, MA 02163
    →Map & Directions
    →More Contact Information
    • Make a Gift
    • Site Map
    • Jobs
    • Harvard University
    • Trademarks
    • Policies
    • Accessibility
    • Digital Accessibility
    Copyright © President & Fellows of Harvard College.